News & Analysis on Clinical Trial Services & Contract Research And Development
By Melissa Fassbender
- Last updated on
The CRO expanded its regulatory services with the appointment of David Dills to department director.
Dills has more than 28 years of experience in the medical device and pharmaceutical industry.
In his new role as regulatory services department director, Dills told us, “I am delighted to join Cromsource this is an excellent opportunity to make a difference within a CRO that has a proven track record, demonstrated capabilities, strategic goals and future growth plans.”
He added, “Understanding the regulatory challenges that lie ahead and seeing the big picture, from submission and application strategy through product approval and beyond, is motivational as director of regulatory services.
“I also look forward to expanding and launching additional regulatory services within our existing portfolio and certainly liaising and working with our clients and our key stakeholders while capitalizing on our regulatory intelligence capabilities.”